Paulson & Co. - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Paulson & Co. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$251,000
-12.2%
70,8000.0%0.00%0.0%
Q3 2016$286,000
-8.0%
70,8000.0%0.00%0.0%
Q2 2016$311,000
+16.0%
70,8000.0%0.00%
+50.0%
Q1 2016$268,000–70,800–0.00%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders